{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"familial-hyperaldosteronism-type-iii","columns":[{"gene":"","key":"population-5f33375591f9306df61d","label":"Hyperaldosteronism, familial, type III","mondoId":"MONDO:0013359","onsetQualifier":null,"originColumnKey":"MONDO:0013359/OMIM:613677","originalViews":[{"key":"MONDO:0013359/OMIM:613677","label":"Hyperaldosteronism, familial, type III","scopeLabel":"OMIM:613677","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["08bd120ed45fe4ee1e0dc494dcbb6512645dfadde7665dbfaba20aa1c61bac5a","384f3e579f93a71971bd19e1988020735e5ffe8537d23ad1414e0bd575cee483","4687280e9ed6fd6f36e57673bf2dce300596fef3c4cef1cfc84db1bd72dcd20f","620897df2227d51acb1ecfe6b238ee413e150a51434b7b0d9a63931e6fa1ee4c","6ef2207cc666a92c6bd2b44610ed5beb73ad39c2920387d3e0406efacdd70200","9dab3b47e35afe288952a7d5a9272f49774aa5b1d2d5607da9ce3f47163e7f9e","d6270e720ba188443aff9657391f3bdf7b0e0b691b601f8b168278b2a1b135d2","d9d01d464255cf88d0670823638db087bb90f0747aeea43bf56a6455b077ae54","dbad30d5324d913dd6e0164f31157a26988dce3dc504d07e2c9332d188e17e40"],"recordQualifiers":{},"scopeLabel":"OMIM:613677","sourceIds":["OMIM:613677"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-17eba0dd55f1f62cc85f","label":"Familial hyperaldosteronism type III","mondoId":"MONDO:0013359","onsetQualifier":null,"originColumnKey":"MONDO:0013359/ORPHA:251274","originalViews":[{"key":"MONDO:0013359/ORPHA:251274","label":"Familial hyperaldosteronism type III","scopeLabel":"ORPHA:251274","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["4772429970966f719a54b70d66188c4a84e9b409a258be33a38eab18f69d01e9","50c29b2fcd25f7cfd07f4483cfcbad1bacbe4d234ec36ad983ad3ef52f30c11d","5fe0d2040b99c7f09b13e096a4bee70712989dde327a105e1c307cd7b6be4e6e","6192b440236333e52811497e904d2c1a5f0aec9466f3e495622670f94d8d8585","7446e2a51655ec4a2ea2b29df12611369dfce6b697e13b43de773707ef8d9a2c","7e72e5f8976a55e07ea97b82ae29d45e55ad0ee20a6ece5f23f443af8e94defd","ae131af4a0800431b7004b8ab15148e0c7329f8ad2e776a531339c504d5cd007","aee9651597310a65788b61a6894cf61df9a6721b937152d2e51f97d0b01d6d44","b04e8445b71124146d07977a21e18f6ac74f5333c61c6b514313d63111d3d008","b728ae6c56d6419b337246931b4f94bd31b9c1b4e78c45827039bac8bb6e9530","cb57c426de79a3f555c8cf0c32c92edd3a7630593b42152ac3be6db009e6fe64","cc7a38e24ad442fab87d76e57eb95df24eda4de52e0b1a2a96bc2a6c97b67d3b","e132902e67fc2fb7d7b8d79c5e494897d387c61a236c554e1966c94a3b3c5cde","e3642d2e5b05e5437c8a007420da7988ce91f37e4a28d07f8b90992555ee177a","e4fa08012ae4e8cce526c15c111ed0e933b3e02b4a249aabc9df645f4269b7e8","e9a61fa7495f6f84aa1ffd9478dc8d13183cf6cc8d1fa5177a6e504eba7ec57f","f6424ba52592cd52e3db865c7e611fdf6adade4ab94b15a2939b440d8daec87d"],"recordQualifiers":{},"scopeLabel":"ORPHA:251274","sourceIds":["ORPHA:251274"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-5f33375591f9306df61d","population-17eba0dd55f1f62cc85f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040084","HP:0008221","HP:0003351","HP:0011739","HP:0000421","HP:0011740","HP:0002315"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"omim":6,"orphanet":17,"published":3}},"features":[{"hpoId":"HP:0040084","label":"Abnormal circulating renin concentration","primary":true},{"hpoId":"HP:0008221","label":"Adrenal hyperplasia","primary":true},{"hpoId":"HP:0003351","label":"Decreased circulating renin concentration","primary":true},{"hpoId":"HP:0011739","label":"Dexamethasone-suppressible primary hyperaldosteronism","primary":true},{"hpoId":"HP:0000421","label":"Epistaxis","primary":true},{"hpoId":"HP:0011740","label":"Glucocortocoid-insensitive primary hyperaldosteronism","primary":true},{"hpoId":"HP:0002315","label":"Headache","primary":true},{"hpoId":"HP:0002150","label":"Hypercalciuria","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002900","label":"Hypokalemia","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0002170","label":"Intracranial hemorrhage","primary":false},{"hpoId":"HP:0001712","label":"Left ventricular hypertrophy","primary":false},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0200114","label":"Metabolic alkalosis","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0002018","label":"Nausea","primary":false},{"hpoId":"HP:0001959","label":"Polydipsia","primary":false},{"hpoId":"HP:0000103","label":"Polyuria","primary":false},{"hpoId":"HP:0001657","label":"Prolonged QT interval","primary":false},{"hpoId":"HP:0000360","label":"Tinnitus","primary":false}],"ledeHtml":"A rare heritable form of primary aldosteronism (PA) that is characterized by early-onset severe hypertension, non- glucocorticoid-remediable hyperaldosteronism, overproduction of 18-oxocortisol and 18-hydroxycortisol, and profound hypokalemia.","mondoId":"MONDO:0013359","node":{"canonicalSlug":"familial-hyperaldosteronism-type-iii","comparisons":[{"documentSha256":"af8816dbbfaa4a637f0aba7a052096caf62e546aab923d7802ee2ff2cbf12ee3","key":"legacy-familial-hyperaldosteronism","kind":"legacy","label":"familial hyperaldosteronism","memberIds":["MONDO:0007080","MONDO:0013359","MONDO:0014200","MONDO:0014875","MONDO:0016525"],"mondoId":"MONDO:0016525","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/familial-hyperaldosteronism.af8816dbbfaa4a637f0aba7a052096caf62e546aab923d7802ee2ff2cbf12ee3.json"},{"documentSha256":"43a80b93c19f2aebe625ef5ea18c3cd0b59ed004ce48da183812054416e9bb9a","key":"expanded-familial-hyperaldosteronism","kind":"expanded","label":"familial hyperaldosteronism","memberIds":["MONDO:0007080","MONDO:0011576","MONDO:0013359","MONDO:0014200","MONDO:0014875","MONDO:0016525"],"mondoId":"MONDO:0016525","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-43a80b93c19f2aebe625.43a80b93c19f2aebe625ef5ea18c3cd0b59ed004ce48da183812054416e9bb9a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Familial hyperaldosteronism type III","originalSourceId":"ORPHA:251274","paragraphs":["A rare heritable form of primary aldosteronism (PA) that is characterized by early-onset severe hypertension, non- glucocorticoid-remediable hyperaldosteronism, overproduction of 18-oxocortisol and 18-hydroxycortisol, and profound hypokalemia."],"rawAttribution":"MONDO:0013359","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:34Z","upstream":"MONDO:0013359","url":"https://rarediseases.info.nih.gov/diseases/12362"},"ownColumnKeys":["population-5f33375591f9306df61d","population-17eba0dd55f1f62cc85f"],"publication":"published","relationships":[{"kind":"parent","label":"familial hyperaldosteronism","mondoId":"MONDO:0016525","slug":"familial-hyperaldosteronism"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"reported","key":"08bd120ed45fe4ee1e0dc494dcbb6512645dfadde7665dbfaba20aa1c61bac5a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"OMIM:613677","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"384f3e579f93a71971bd19e1988020735e5ffe8537d23ad1414e0bd575cee483","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0008221","is_excluded":false,"label":"Adrenal hyperplasia","onset_id":null,"reference":"OMIM:613677","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4687280e9ed6fd6f36e57673bf2dce300596fef3c4cef1cfc84db1bd72dcd20f","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000103","is_excluded":false,"label":"Polyuria","onset_id":null,"reference":"OMIM:613677","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4772429970966f719a54b70d66188c4a84e9b409a258be33a38eab18f69d01e9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001959","is_excluded":false,"label":"Polydipsia","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"50c29b2fcd25f7cfd07f4483cfcbad1bacbe4d234ec36ad983ad3ef52f30c11d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008221","is_excluded":false,"label":"Adrenal hyperplasia","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"5fe0d2040b99c7f09b13e096a4bee70712989dde327a105e1c307cd7b6be4e6e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011739","is_excluded":true,"label":"Dexamethasone-suppressible primary hyperaldosteronism","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6192b440236333e52811497e904d2c1a5f0aec9466f3e495622670f94d8d8585","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011740","is_excluded":false,"label":"Glucocortocoid-insensitive primary hyperaldosteronism","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"620897df2227d51acb1ecfe6b238ee413e150a51434b7b0d9a63931e6fa1ee4c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"OMIM:613677","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6ef2207cc666a92c6bd2b44610ed5beb73ad39c2920387d3e0406efacdd70200","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"PCS","frequency_raw":"13/13","hpo_id":"HP:0003351","is_excluded":false,"label":"Decreased circulating renin concentration","onset_id":null,"reference":"OMIM:613677;PMID:21311022","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7446e2a51655ec4a2ea2b29df12611369dfce6b697e13b43de773707ef8d9a2c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001712","is_excluded":false,"label":"Left ventricular hypertrophy","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7e72e5f8976a55e07ea97b82ae29d45e55ad0ee20a6ece5f23f443af8e94defd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"9dab3b47e35afe288952a7d5a9272f49774aa5b1d2d5607da9ce3f47163e7f9e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"PMID:21311022","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ae131af4a0800431b7004b8ab15148e0c7329f8ad2e776a531339c504d5cd007","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0040084","is_excluded":false,"label":"Abnormal circulating renin concentration","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aee9651597310a65788b61a6894cf61df9a6721b937152d2e51f97d0b01d6d44","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b04e8445b71124146d07977a21e18f6ac74f5333c61c6b514313d63111d3d008","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001657","is_excluded":false,"label":"Prolonged QT interval","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b728ae6c56d6419b337246931b4f94bd31b9c1b4e78c45827039bac8bb6e9530","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002018","is_excluded":false,"label":"Nausea","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb57c426de79a3f555c8cf0c32c92edd3a7630593b42152ac3be6db009e6fe64","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002150","is_excluded":false,"label":"Hypercalciuria","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc7a38e24ad442fab87d76e57eb95df24eda4de52e0b1a2a96bc2a6c97b67d3b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d6270e720ba188443aff9657391f3bdf7b0e0b691b601f8b168278b2a1b135d2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001959","is_excluded":false,"label":"Polydipsia","onset_id":null,"reference":"OMIM:613677","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d9d01d464255cf88d0670823638db087bb90f0747aeea43bf56a6455b077ae54","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002150","is_excluded":false,"label":"Hypercalciuria","onset_id":null,"reference":"OMIM:613677","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"dbad30d5324d913dd6e0164f31157a26988dce3dc504d07e2c9332d188e17e40","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:613677","disease_name":"Hyperaldosteronism, familial, type III","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:21311022","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e132902e67fc2fb7d7b8d79c5e494897d387c61a236c554e1966c94a3b3c5cde","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e3642d2e5b05e5437c8a007420da7988ce91f37e4a28d07f8b90992555ee177a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e4fa08012ae4e8cce526c15c111ed0e933b3e02b4a249aabc9df645f4269b7e8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0200114","is_excluded":false,"label":"Metabolic alkalosis","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e9a61fa7495f6f84aa1ffd9478dc8d13183cf6cc8d1fa5177a6e504eba7ec57f","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002170","is_excluded":false,"label":"Intracranial hemorrhage","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f6424ba52592cd52e3db865c7e611fdf6adade4ab94b15a2939b440d8daec87d","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:251274","disease_name":"Familial hyperaldosteronism type III","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000360","is_excluded":false,"label":"Tinnitus","onset_id":null,"reference":"ORPHA:251274","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12362\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013359\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0013359</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare heritable form of primary aldosteronism (PA) that is characterized by early-onset severe hypertension, non- glucocorticoid-remediable hyperaldosteronism, overproduction of 18-oxocortisol and 18-hydroxycortisol, and profound hypokalemia.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12362\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"familial-hyperaldosteronism-type-iii","sourceDocuments":[{"name":"GARD: Familial hyperaldosteronism type III","reviewed":null,"source_release":"2026-10-25T03:41:34Z","url":"https://rarediseases.info.nih.gov/diseases/12362"},{"name":"MONDO: familial hyperaldosteronism type III","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013359"}],"sourceNote":"","synonyms":["familial hyperaldosteronism type 3","FH III","FH-III","FH3","HALD3"],"takeawayHtml":"","title":"familial hyperaldosteronism type III"},"schemaVersion":1}
